For example, all-trans retinoic acid (ATRA) induced expression of CD38 and folate receptor-β (FRβ), which in combination with CD38-specific CAR T-cells resulted in elimination of AML blasts in preclinical studies [63,64]. This evidence concerns the gene CD38 and acute myeloid leukemia.